Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tivdak
Pharma
ESMO: Seagen, Genmab's Tivdak excel in cervical cancer study
Seagen's Tivdak produced a 30% reduction in the risk of death compared to chemo for second-line cervical cancer patients.
Kevin Dunleavy
Oct 22, 2023 10:30am
Seagen, Genmab's Tivdak meets goals in cervical cancer trial
Sep 5, 2023 11:10am
Seagen, Genmab run 'CeMe' cervical cancer campaign
Feb 10, 2022 10:34am
Seagen, Genmab's cervical cancer med Tivdak scores FDA nod
Sep 21, 2021 10:00am